On April 6th, one of the "key members" of the SIS series products of Biosis Healing - 博瑞金 Oral Biological Graft, was approved by NMPA for the registration of Class III medical devices [国械注准 20223170457].
Two papers have been included in the full text of the international top journal "Materials Today Bio" in the field of materials and "Cell Proliferation", a Q1 journal of cell biology, with impact factors of 7.348 and 6.831 respectively.
The Dura Repair Mesh, one of the "key member" of the SIS series products, was awarded the "Beijing New Technology and New Product (Service) Certificate".
2021 annual promotional video Announcement of the 2021 annual evaluation results
"I am a doctor, and I feel more deeply and sensitively about the pain points of clinical medical care than other entrepreneurs. My company is rooted in the clinic and serves the clinic. In the future, I have a plan, and Biosis Healing will be a comprehensive solution provider for surgery."
On December 24th, the latest research results of Biosis Healing SIS hydrogels were released in "Materials Today Bio", the top international journal in the field of materials. In 2021, the scientific research output ended with the result of "6 papers, with a total impact factor of 62.055.
This is the sixth time that Biosis Healing won the bid in the centralized procurement since December, following the winning bids for Dura Repair Mesh, Synthetic patch, and minimally invasive surgical instruments.
Composites Part B, titled "Asymmetric SIS Membranes Specifically Loaded with Exosomes through the Modification of Engineered Recombinant Peptides for Guide Bone Regeneration", published the full text in Biosis Healing’s independent intellectual property research results in the field of SIS biomaterials.
Ligating clips was approved by the NMPA for the registration of Class III medical devices.
The leaders of the company reiterated to the participants the determination and strength of strict prevention and control and joint fight against the epidemic.